Lam Research Corporation $LRCX Shares Bought by Winslow Capital Management LLC

by · The Markets Daily

Winslow Capital Management LLC increased its stake in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 7.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,310,124 shares of the semiconductor company’s stock after buying an additional 540,252 shares during the quarter. Lam Research comprises approximately 2.7% of Winslow Capital Management LLC’s investment portfolio, making the stock its 9th biggest position. Winslow Capital Management LLC owned about 0.66% of Lam Research worth $808,907,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. IMG Wealth Management Inc. bought a new position in Lam Research in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research in the second quarter valued at about $27,000. REAP Financial Group LLC bought a new position in Lam Research in the second quarter valued at about $31,000. Bank of Jackson Hole Trust raised its holdings in Lam Research by 111.1% in the 2nd quarter. Bank of Jackson Hole Trust now owns 380 shares of the semiconductor company’s stock valued at $37,000 after buying an additional 200 shares during the last quarter. Finally, Barnes Dennig Private Wealth Management LLC acquired a new stake in Lam Research in the second quarter valued at $38,000. Institutional investors own 84.61% of the company’s stock.

Insider Buying and Selling

In related news, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. The trade was a 17.21% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 102,608 shares of company stock worth $14,916,496. Insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

NASDAQ:LRCX opened at $158.70 on Monday. The stock has a 50-day simple moving average of $150.02 and a two-hundred day simple moving average of $117.59. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $167.15. The firm has a market capitalization of $199.33 billion, a PE ratio of 34.96, a P/E/G ratio of 1.63 and a beta of 1.77.

Lam Research (NASDAQ:LRCXGet Free Report) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on LRCX. JPMorgan Chase & Co. boosted their price objective on Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 23rd. Needham & Company LLC raised their price objective on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Rothschild & Co Redburn upped their price objective on Lam Research from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. Susquehanna lifted their price objective on shares of Lam Research from $135.00 to $200.00 and gave the company a “positive” rating in a research note on Thursday, October 23rd. Finally, Hsbc Global Res upgraded Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Twenty-six investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $152.87.

Read Our Latest Stock Analysis on Lam Research

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Recommended Stories